| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |